Affilogic is a private biotech company specialized in discovering and developing Nanofitins® through early-stage collaborations with worldwide industry leaders in the pharmaceutical sector.

These affinity proteins can be designed as targeted inhibitors, or as vectors for specific addressing of cells and tissues. Affilogic follows the science to any therapeutic area as long as an innovative Nanofitin-based biotherapy can make a difference to meet patients’ needs. Usual systemic routes can be travelled by Nanofitins®, but their intrinsic properties make them amenable to other routes, such as oral route and pulmonary delivery.

Affilogic wants to hear from you!

BIO International Convention 2024 San-Diego

BIO International Convention 2024 San-Diego

Come and meet us at the BIO International Convention San Diego – USA
Jun 3-6, 2024

Visit the event website

World Vaccine Congress Washington 2024

World Vaccine Congress Washington 2024

Come and meet us at the World Vaccine Congress Washington – USA
Apr 1-4, 2024

Visit the event website

Technology

Your Nanofitins®

Our platforms